Tuberculosis preventive chemotherapy in the HIV infected in the regions of the Russian Federation with high prevalence of HIV infection
Abstract
In 2014 in 18 regions of the Russian Federation with the high prevalence of HIV infection the part of HIV patients covered by tuberculosis preventive chemotherapy was extremely small making 5.8% out of the total number. And the part of children and adolescents in the age from 0 to 17 years old made only 1.8%. Only in 6 out of 18 Russian regions the preventive tuberculosis chemotherapy was conducted among new HIV patients. In 15 Russian regions among HIV infected children and adolescents in the age from 0 to 17 years old no preventive tuberculosis chemotherapy was done.
About the Authors
E. B. Tsybikova
Central Research Institute for Public Health Organization and Informatization
Russian Federation
Moscow
Russian Federation
Moscow
N. A. Zubova
Republican Clinical TB Dispensary, Mordovia Republic
Russian Federation
Saransk
Russian Federation
Saransk
References
1. Lecheniye tuberkuleza. Rekomendatsii. (chetvertoye izdaniye). (Russ. ed.: Treatment of tuberculosis: guidelines, 4th ed.) WHO, Geneva, 2011, 183 p.
2. Rukovodstvo po monitoringu i sovmestnoy deyatel’nosti po bor’be s TB/VICH. (Russ. Ed.: A Guide to monitoring and evaluation for collaborative TB/HIV activities). WHO, Geneva, 2011, 51 p. http://whqlibdoc.who.int/publications/2011/9789244598191_rus.pdf
3. Rukovodyaschie printsipy dlya intensivnogo vyavleniya tuberkuleza i profilakticheskoy terapii izoniazidom u lyudey, zhivuschikh s VICH, v usloviyakh nekhvatki resursov. (Russ. Ed.: Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings). WHO, Geneva, 2011, 39 p. http://whqlibdoc.who.int/publications/2011/9789244500705_rus.pdf
4. Federal’nye klinicheskie rekomendatsii po diagnostike i lecheniyu tuberkuleza u bolnykh VICH-infektsiey. [Federal clinical recommendations on diagnostics and treatment of tuberculous in HIV patients]. Moscow, Tver, OOO Izdatelstvo Triada Publ., 2014, 56 p.
5. Сain K.P. et al. An algoritm for tuberculosis screening and diagnosis in people with HIV. N. Engl. J. Med., 2010, vol. 362, pp. 707-716.
6. Fitzgerald D.W. et al. Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1 infected individuals: a randomized trial. Lancet, 2000, vol. 356, pp. 1470-1474.
7. Getahun H. et al. HIV infection associated tuberculosis: the epidemiology and the response. Clin. Infect. Dis., 2010, vol. 50, pp. 201-207.
8. Golub J.E. et al. Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: prospective cohort. AIDS, 2009, vol. 23, pp. 631-636.
9. Granich R. et al. Prevention of tuberculosis in people living with HIV. Clin.Infect. Dis., 2010, vol. 50, pp. 215-222.
10. Kimerling M.E. et al. Prevalence of pulmonary tuberculosis among HIV-infected persons in a home care program in Phnom Penh, Cambodia. Int. J. Tub. Lung Dis., 2002, vol. 6, pp. 988-994.
11. WHO Three Is Meeting: Intensified case funding (ICF), Isoniazid preventive therapy (IPT) and TB Infection control (IC) for people living with HIV. Report of a joint WHO HIV/AIDS and TB department meeting. Geneva, WHO, 2008. http://who.int/hiv/pub/meeting-reports/WHO_3Is_meeting_report.pdf
Review
For citations:
Tsybikova E.B., Zubova N.A. Tuberculosis preventive chemotherapy in the HIV infected in the regions of the Russian Federation with high prevalence of HIV infection. Tuberculosis and Lung Diseases. 2016;94(2):16-25. (In Russ.)
Views:
753
Email this article 